• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用单荧光探针不对称 PCR 熔解曲线分析法快速检测伊立替康相关的 UGT1A1*28 多态性。

Rapid detection of the irinotecan-related UGT1A1*28 polymorphism by asymmetric PCR melting curve analysis using one fluorescent probe.

机构信息

Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China.

Engineering Research Centre of Molecular Diagnostics, Ministry of Education, State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China.

出版信息

J Clin Lab Anal. 2022 Aug;36(8):e24578. doi: 10.1002/jcla.24578. Epub 2022 Jun 29.

DOI:10.1002/jcla.24578
PMID:35766440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9396174/
Abstract

BACKGROUND

Determination of UGT1A1 (TA) polymorphism prior to irinotecan therapy is necessary to avoid severe adverse drug effects. Thus, accurate and reliable genotyping methods for (TA) polymorphism are highly desired. Here, we present a new method for polymerase chain reaction (PCR) melting curve analysis using one fluorescent probe to discriminate the UGT1A1*1 [(TA) ] and *28 [(TA) ] genotypes.

METHODS

After protocol optimization, this technique was applied for genotyping of 64 patients (including 23 with UGT1A1*1/*1, 22 with *1/*28, and 19 with *28/*28) recruited between 2016 and 2021 in China-Japan Friendship Hospital. The accuracy of the method was evaluated by comparing the results with those of direct sequencing and fragment analysis. The intra- and inter-run precision of the melting temperatures (T s) were calculated to assess the reliability, and the limit of detection was examined to assess the sensitivity.

RESULTS

All genotypes were correctly identified with the new method, and its accuracy was higher than that of fragment analysis. The intra- and inter-run coefficients of variation for the T s were both ≤0.27%, with standard deviations ≤0.14°C. The limit of detection was 0.2 ng of input genomic DNA.

CONCLUSION

The developed PCR melting curve analysis using one fluorescent probe can provide accurate, reliable, rapid, simple, and low-cost detection of UGT1A1 (TA) polymorphism, and its use can be easily generalized in clinical laboratories with a fluorescent PCR platform.

摘要

背景

在使用伊立替康治疗前确定 UGT1A1(TA)多态性是避免严重药物不良反应所必需的。因此,非常需要准确可靠的(TA)多态性基因分型方法。在这里,我们提出了一种新的聚合酶链反应(PCR)熔解曲线分析方法,使用一个荧光探针来区分 UGT1A11[(TA)]和28[(TA)]基因型。

方法

在方案优化后,该技术应用于 2016 年至 2021 年间在中国-日本友好医院招募的 64 例患者(包括 23 例 UGT1A1*1/1、22 例1/28 和 19 例28/*28)的基因分型。通过与直接测序和片段分析的结果进行比较来评估方法的准确性。计算熔解温度(Ts)的内和运行精度以评估可靠性,并检查检测限以评估灵敏度。

结果

所有基因型均通过新方法正确识别,其准确性高于片段分析。Ts 的内和运行变异系数均≤0.27%,标准偏差均≤0.14°C。检测限为 0.2ng 输入基因组 DNA。

结论

使用一个荧光探针开发的 PCR 熔解曲线分析可以提供准确、可靠、快速、简单和低成本的 UGT1A1(TA)多态性检测,并且可以在具有荧光 PCR 平台的临床实验室中轻松推广使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/9396174/863fc0805155/JCLA-36-e24578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/9396174/863fc0805155/JCLA-36-e24578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/9396174/863fc0805155/JCLA-36-e24578-g002.jpg

相似文献

1
Rapid detection of the irinotecan-related UGT1A1*28 polymorphism by asymmetric PCR melting curve analysis using one fluorescent probe.采用单荧光探针不对称 PCR 熔解曲线分析法快速检测伊立替康相关的 UGT1A1*28 多态性。
J Clin Lab Anal. 2022 Aug;36(8):e24578. doi: 10.1002/jcla.24578. Epub 2022 Jun 29.
2
Rapid detection of the irinotecan-related UGT1A1 & 5-fluorouracil related DPYD polymorphism by asymmetric polymerase chain reaction melting curve analysis.通过不对称聚合酶链反应熔解曲线分析快速检测伊立替康相关的UGT1A1及5-氟尿嘧啶相关的DPYD基因多态性
Clin Chim Acta. 2024 Jul 15;561:119761. doi: 10.1016/j.cca.2024.119761. Epub 2024 Jun 5.
3
Snapback primer genotyping of the Gilbert syndrome UGT1A1 (TA)(n) promoter polymorphism by high-resolution melting.高分辨率熔解技术 snapback 引物法对吉尔伯特综合征 UGT1A1(TA)(n)启动子多态性的基因分型。
Clin Chem. 2011 Sep;57(9):1303-10. doi: 10.1373/clinchem.2011.166306. Epub 2011 Jul 19.
4
Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA) Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?比较八种技术以确定 UGT1A1(TA)重复多态性的基因型:基因分型错误的潜在临床后果?
Int J Mol Sci. 2020 Jan 30;21(3):896. doi: 10.3390/ijms21030896.
5
DNA base bulge vs unmatched end formation in probe-based diagnostic insertion/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR.基于探针的诊断性插入/缺失基因分型中DNA碱基凸起与不匹配末端形成:通过实时荧光PCR对UGT1A1 (TA)(n)多态性进行基因分型
Clin Chem. 2000 Dec;46(12):1939-45.
6
Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai.以上海为中心的多中心回顾性研究分析晚期结直肠癌患者伊立替康为基础化疗的 UGT1A1*28 基因型和 SN-38 药代动力学。
J Cancer Res Clin Oncol. 2013 Sep;139(9):1579-89. doi: 10.1007/s00432-013-1480-7. Epub 2013 Jul 28.
7
Rapid UGT1A1 (TA)(n) genotyping by high resolution melting curve analysis for Gilbert's syndrome diagnosis.采用高分辨率熔解曲线分析技术快速检测 UGT1A1(TA)(n) 基因型用于吉尔伯特综合征的诊断。
Clin Chim Acta. 2010 Feb;411(3-4):246-9. doi: 10.1016/j.cca.2009.11.013. Epub 2009 Nov 20.
8
A clinical PCR fragment analysis assay for TA repeat sizing in the UGT1A1 promoter region.用于 UGT1A1 启动子区域 TA 重复大小测定的临床 PCR 片段分析检测方法。
Clin Chim Acta. 2013 Jun 25;422:1-4. doi: 10.1016/j.cca.2013.03.023. Epub 2013 Mar 29.
9
Genetic polymorphism in the phenobarbital-responsive enhancer module of the UDP-glucuronosyltransferase 1A1 gene and irinotecan toxicity.尿苷二磷酸葡萄糖醛酸基转移酶1A1基因的苯巴比妥反应增强子模块中的基因多态性与伊立替康毒性
Pharmacogenet Genomics. 2005 Jan;15(1):35-41. doi: 10.1097/01213011-200501000-00006.
10
UGT1A1 (TA)n genotyping in sickle-cell disease: high resolution melting (HRM) curve analysis or direct sequencing, what is the best way?对镰状细胞病患者进行 UGT1A1(TA)n 基因分型:高分辨率熔解曲线分析还是直接测序,哪种方法更好?
Clin Chim Acta. 2013 Sep 23;424:258-60. doi: 10.1016/j.cca.2013.06.023. Epub 2013 Jul 1.

引用本文的文献

1
detection using high-resolution agarose gel electrophoresis.使用高分辨率琼脂糖凝胶电泳进行检测。
Heliyon. 2024 Apr 27;10(9):e30465. doi: 10.1016/j.heliyon.2024.e30465. eCollection 2024 May 15.
2
Photoinduced electron transfer detection method for identifying UGT1A1*28 microsatellites.基于光诱导电子转移的 UGT1A1*28 微卫星鉴定方法。
PLoS One. 2023 Aug 3;18(8):e0289506. doi: 10.1371/journal.pone.0289506. eCollection 2023.

本文引用的文献

1
TaqMan real time PCR for the Detection of the Gilbert's Syndrome Markers UGT1A1*28; UGT1A1*36 and UGT1A1*37.TaqMan 实时 PCR 检测 Gilbert 综合征标志物 UGT1A1*28、UGT1A1*36 和 UGT1A1*37。
Mol Biol Rep. 2021 May;48(5):4953-4959. doi: 10.1007/s11033-021-06454-2. Epub 2021 Jun 4.
2
Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time.进行治疗前 UGT1A1 基因分型,以降低伊立替康引起的严重毒性风险:是时候了。
Eur J Cancer. 2020 Dec;141:9-20. doi: 10.1016/j.ejca.2020.09.007. Epub 2020 Oct 23.
3
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by Status in Patients With Locally Advanced Rectal Cancer.
多中心、随机、III 期临床试验:卡培他滨和伊立替康新辅助放化疗,指导局部进展期直肠癌患者的 状态。
J Clin Oncol. 2020 Dec 20;38(36):4231-4239. doi: 10.1200/JCO.20.01932. Epub 2020 Oct 29.
4
Association of UGT1A1*6 polymorphism with irinotecan-based chemotherapy reaction in colorectal cancer patients: a systematic review and a meta-analysis.UGT1A1*6 多态性与结直肠癌患者伊立替康为基础的化疗反应的关联:系统评价和荟萃分析。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20200576.
5
Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST).确定UGT1A1基因多态性,以指导一线使用贝伐单抗和FOLFIRI方案治疗的转移性结直肠癌患者伊立替康剂量递增(PURE FIST研究)。
Eur J Cancer. 2020 Oct;138:19-29. doi: 10.1016/j.ejca.2020.05.031. Epub 2020 Aug 20.
6
Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy.伊立替康为基础化疗的泰国结直肠癌患者中药物代谢酶和转运体的作用。
Sci Rep. 2020 Aug 10;10(1):13486. doi: 10.1038/s41598-020-70351-0.
7
Pharmacogenetic impact of UGT1A1 polymorphisms on pulmonary neuroendocrine tumours treated with metronomic irinotecan-based chemotherapy in Chinese populations.UGT1A1 多态性对接受基于伊立替康的节拍化疗的中国人群肺神经内分泌肿瘤的药物遗传学影响。
J Pharm Pharmacol. 2020 Nov;72(11):1528-1535. doi: 10.1111/jphp.13333. Epub 2020 Jul 31.
8
Effects of variation status and enzyme activity for UDP-glucuronosyltransferase 1A1 gene on neonatal hyperbilirubinemia.UDP-葡萄糖醛酸基转移酶1A1基因的变异状态和酶活性对新生儿高胆红素血症的影响。
Pediatr Neonatol. 2020 Oct;61(5):506-512. doi: 10.1016/j.pedneo.2020.05.009. Epub 2020 Jun 4.
9
Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang.UGT1A1 基因多态性与转移性结直肠癌伊立替康化疗的相关性:来自广西壮族自治区的研究。
BMC Gastroenterol. 2020 Apr 7;20(1):96. doi: 10.1186/s12876-020-01227-w.
10
Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA) Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?比较八种技术以确定 UGT1A1(TA)重复多态性的基因型:基因分型错误的潜在临床后果?
Int J Mol Sci. 2020 Jan 30;21(3):896. doi: 10.3390/ijms21030896.